Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Anne Macnamara, Celia S. Chen, Andrew Davies, Charlotte Sloan & Tobias Loetscher. (2023) Low vision devices for age-related macular degeneration: a systematic review. Disability and Rehabilitation: Assistive Technology 18:7, pages 998-1010.
Read now
Read now
Zheting Zhang, Konstadina Griva, William Rojas-Carabali, Gazal Patnaik, Renee Liu, Lucia Sobrin, John H. Kempen, Robert P. Finger, Vishali Gupta, Bryan Ang & Rupesh Agrawal. (2023) Psychosocial Well-Being and Quality of Life in Uveitis: A Review. Ocular Immunology and Inflammation 0:0, pages 1-15.
Read now
Read now
Kanji Takahashi, Tomohiro Iida, Susumu Ishida, Bruce Crawford, Yoko Sakai, Akikazu Mochizuki, Ryuta Tsujiuchi, Satoru Tanaka & Kota Imai. (2022) Effectiveness of Current Treatments for Wet Age-Related Macular Degeneration in Japan: A Systematic Review and Pooled Data Analysis. Clinical Ophthalmology 16, pages 531-540.
Read now
Read now
Miguel Thibaut, Muriel Boucart & Thi Ha Chau Tran. (2020) Object search in neovascular age‐related macular degeneration: the crowding effect. Clinical and Experimental Optometry 103:5, pages 648-655.
Read now
Read now
Shigehiko Kitano, Taiji Sakamoto, Rei Goto, Ayako Fukushima, Anne-Lise Vataire & Yusuke Hikichi. (2019) The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in Japan. Journal of Medical Economics 22:3, pages 254-265.
Read now
Read now
Giancarlo A Garcia, Matin Khoshnevis, Jesse Gale, Starleen E Frousiakis, Tiffany J Hwang, Lissa Poincenot, Rustum Karanjia, David Baron & Alfredo A Sadun. (2017) Profound vision loss impairs psychological well-being in young and middle-aged individuals. Clinical Ophthalmology 11, pages 417-427.
Read now
Read now
Irini Chatziralli, Panagiotis Mitropoulos, Efstratios Parikakis, Dimitrios Niakas & Georgios Labiris. (2017) Risk Factors for Poor Quality of Life among Patients with Age-Related Macular Degeneration. Seminars in Ophthalmology 32:6, pages 772-780.
Read now
Read now
Ann P. Murchison, Julia A. Haller, Eileen Mayro, Lisa Hark, Emily Gower, Carrie Huisingh, Lindsay Rhodes, David S. Friedman, David J. Lee & Byron L. Lam. (2017) Reaching the Unreachable: Novel Approaches to Telemedicine Screening of Underserved Populations for Vitreoretinal Disease. Current Eye Research 42:7, pages 963-970.
Read now
Read now
Articles from other publishers (46)
Raúl Martínez-Castillo, Carmen González-Gallardo, José I. Muñoz-Ávila, Pilar Font, Marta Villalba-González, Indira Stoikow, Ignacio Fernández-Choquet de Isla, Francisco Pugliese, Roberto Anaya-Alaminos, José L. García-Serrano, Francisco Hermoso-Fernández, Fabio Contieri, José E. Muñoz-de-Escalona-Rojas, Lorena Pérez-Fajardo, Mario Blanco-Blanco, Yolanda Jiménez-Gómez & Miguel González-Andrades. (2023) Treatment of neovascular age-related macular degeneration within 48 h from diagnosis improves long-term functional outcome. Biomedicine & Pharmacotherapy 160, pages 114368.
Crossref
Crossref
Robyn H Guymer & Thomas G Campbell. (2023) Age-related macular degeneration. The Lancet 401:10386, pages 1459-1472.
Crossref
Crossref
Ahnul Ha, Su Hwan Kim, Goneui Kang, Hyung-Jin Yoon & Young Kook Kim. (2023) Association between Sight-Threatening Eye Diseases and Death by Suicide in South Korea. Ophthalmology.
Crossref
Crossref
Štefanija Kolačko, Jurica Predović, Anamaria Tomić & Valentina Oršulić. (2023) Life Quality in Patients with Impaired Visual Acuity Undergoing Intravitreal Medication Applications. International Journal of Environmental Research and Public Health 20:4, pages 2879.
Crossref
Crossref
Ezatollah Memarzadeh & Saeid Heidari-Soureshjani. (2022) The Relationship between Statin and Risk of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. Journal of Ophthalmology 2022, pages 1-9.
Crossref
Crossref
Daniel Caballe-Fontanet, Cristina Alvarez-Peregrina, Neus Busquet-Duran, Eduard Pedemonte-Sarrias, Cristina Andreu-Vázquez & Miguel Ángel Sánchez-Tena. (2022) Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 19:2, pages 820.
Crossref
Crossref
Yuji Oshima, Yumi Ishibashi, Naoyasu Umeda, Tatsuo Nagata, Shigeo Yoshida, Eiichi Uchio, Hiroyuki Kondo, Koh-hei Sonoda & Tatsuro Ishibashi. (2021) Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study. BMC Ophthalmology 21:1.
Crossref
Crossref
Seyed Ahmad Rasoulinejad & Faezeh Maroufi. (2021) CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases. Molecular Biotechnology 63:9, pages 768-779.
Crossref
Crossref
Jan Kremláček, Jana Nekolová, Markéta Středová, Jana Langrová, Jana Szanyi, Miroslav Kuba, Zuzana Kubová, František Vít, Petr Voda, Martina Veselá & Naďa Jirásková. (2021) Vision before and after scharioth macular lens implantation in patients with AMD: an electrophysiological study. Documenta Ophthalmologica 143:1, pages 17-31.
Crossref
Crossref
Shigeru Honda, Yasuo Yanagi, Hideki Koizumi, Yirong Chen, Satoru Tanaka, Manami Arimoto & Kota Imai. (2021) Impact of neovascular age-related macular degeneration: burden of patients receiving therapies in Japan. Scientific Reports 11:1.
Crossref
Crossref
Karen Marie Poulsen, Tina Jensen & Karin Bundgaard. (2021) Hvordan kan medinddragende rehabilitering understøtte livskvaliteten hos patienter med AMD?. Klinisk Sygepleje 35:2, pages 99-113.
Crossref
Crossref
Jelena PoticCiara Bergin, Clarice Giacuzzo, Lazaros Konstantinidis, Alejandra Daruich & Thomas J. Wolfensberger. (2021) APPLICATION OF MODIFIED NEI VFQ-25 AFTER RETINAL DETACHMENT TO VISION-RELATED QUALITY OF LIFE. Retina 41:3, pages 653-660.
Crossref
Crossref
Neil M. Schultz, Lydia Braunack-Mayer, Jason Schwartz & Luis Gaspar. (2021) The Patient Experience: Symptoms and Impact of Dry Age-Related Macular Degeneration. Ophthalmology and Therapy 10:1, pages 151-164.
Crossref
Crossref
Aneesha Ahluwalia, Liangbo L. Shen & Lucian V. Del Priore. (2020) Central geographic atrophy vs. neovascular age–related macular degeneration: differences in longitudinal vision-related quality of life. Graefe's Archive for Clinical and Experimental Ophthalmology 259:2, pages 307-316.
Crossref
Crossref
Kuo-Meng Liao, Wei-Chi Wu, Yuh Jang, Fan-Ya Su & Li-Ting Tsai. (2021) Impacts of monocular, binocular, and functional visual acuity on vision-related quality of life in patients with type 2 diabetes. Scientific Reports 11:1.
Crossref
Crossref
R.R. Fayzrakhmanov, V.Yu. Voropaev, A.V. Sukhanova & E.O. Shatalova. (2021) Antiangiogenic therapy of neovascular age-related macular degeneration. Vestnik oftal'mologii 137:1, pages 83.
Crossref
Crossref
Wei Bian, Junli Wan, Mingqiong Tan, Jun Su, Yi Yuan, Zonghua Wang & Shiying Li. (2020) Predictors of health-related quality of life in Chinese patients receiving treatment for neovascular age-related macular degeneration: a prospective longitudinal study. BMC Ophthalmology 20:1.
Crossref
Crossref
Daniel Caballe-Fontanet, Cristina Alvarez-Peregrina, Neus Busquet-Duran, Eduard Pedemonte-Sarrias & Miguel Angel Sanchez-Tena. (2020) Improvement of the Quality of Life in Patients with Age-Related Macular Degeneration by Using Filters. International Journal of Environmental Research and Public Health 17:18, pages 6751.
Crossref
Crossref
Sitara H. Hirji, Jeffrey M. Liebmann, Donald C. Hood, George A. Cioffi & Dana M. Blumberg. (2020) Macular Damage in Glaucoma is Associated With Deficits in Facial Recognition. American Journal of Ophthalmology 217, pages 1-9.
Crossref
Crossref
F. G. Holz, K. T. Johnson, U. Bauer-Steinhusen, C. Rech, T. Machewitz, S. Müller & R. P. Finger. (2019) ANDROMEDA – Eine Untersuchung von Einflussfaktoren auf die Adhärenz von Patienten mit neovaskulärer altersabhängiger Makuladegeneration mithilfe des neu konzipierten Patientenfragebogens LAF-IVTANDROMEDA—an investigation of factors influencing the adherence of patients with neovascular age-related macular degeneration using the newly developed patient questionnaire LAF-IVT. Der Ophthalmologe 117:8, pages 765-774.
Crossref
Crossref
Lavanya Uruthiramoorthy, Cindy M.L. Hutnik, Kathy N. Speechley, Monali S. Malvankar‐Mehta & Daniel J Lizotte. (2020) Estimating patient‐reported outcomes for glaucoma management: A cross‐sectional study. Journal of Evidence-Based Medicine 13:1, pages 8-16.
Crossref
Crossref
Elma Jelin, Torbjørn Wisløff, Morten C. Moe & Turid Heiberg. (2019) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population. Health and Quality of Life Outcomes 17:1.
Crossref
Crossref
Fumi Gomi, Hideyuki Migita, Toshiaki Sakaguchi, Hiromi Okada, Tamotsu Sugawara & Yusuke Hikichi. (2019) Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting. Japanese Journal of Ophthalmology 63:6, pages 437-447.
Crossref
Crossref
Elma Jelin, Torbjørn Wisløff, Øystein Kalsnes Jørstad, Turid Heiberg & Morten Carstens Moe. (2019) Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective study. BMJ Open Ophthalmology 4:1, pages e000353.
Crossref
Crossref
A. García-Layana, J. García-Arumí, M. S. Figueroa, L. Arias Barquet, J. M. Ruíz-Moreno, L. Monclús-Arbona & The Spanish AMD Multicenter Group. (2019) Management of Wet Age-Related Macular Degeneration in Spain: Challenges for Treat and Extend Implementation in Routine Clinical Practice. Journal of Ophthalmology 2019, pages 1-10.
Crossref
Crossref
Polona Jaki Mekjavić, Vilma Jūratė Balčiūnienė, Lala Ćeklić, Jan Ernest, Zuzana Jamrichova, Zoltán Zsolt Nagy, Iva Petkova, Sławomir Teper, Ivana Gardašević Topčić & Miroslav Veith. (2019) The Burden of Macular Diseases in Central and Eastern Europe—Implications for Healthcare Systems. Value in Health Regional Issues 19, pages 1-6.
Crossref
Crossref
Elma Jelin, Torbjørn Wisløff, Morten C. Moe & Turid Heiberg. (2018) Development and testing of a patient-derived questionnaire for treatment of neovascular age-related macular degeneration: dimensions of importance in treatment of neovascular age-related macular degeneration. Acta Ophthalmologica 96:8, pages 804-811.
Crossref
Crossref
C. Alvarez-Peregrina, M.A. Sánchez-Tena, D. Caballé-Fontanet, I.J. Thuissard-Vasallo, M.B. Gacimartín-García & C. Orduna-Magán. (2018) Crosscultural adaptation and validation into Spanish of the questionnaire National Eye Institute Visual Function Questionnaire 25. Archivos de la Sociedad Española de Oftalmología (English Edition) 93:12, pages 586-591.
Crossref
Crossref
C. Alvarez-Peregrina, M.A. Sánchez-Tena, D. Caballé-Fontanet, I.J. Thuissard-Vasallo, M.B. Gacimartín-García & C. Orduna-Magán. (2018) Adaptación cultural y validación al castellano del cuestionario National Eye Institute Visual Function Questionnaire 25. Archivos de la Sociedad Española de Oftalmología 93:12, pages 586-591.
Crossref
Crossref
Polona Jaki Mekjavic & Polona Zaletel Benda. (2018) Outcome of 5-Year Treatment of Neovascular Age-Related Macular Degeneration With Intravitreal Anti-VEGF Using “Treat and Extend” Regimen. Frontiers in Medicine 5.
Crossref
Crossref
Ana Carla Schippert, Elma Jelin, Morten C. Moe, Turid Heiberg & Ellen Karine Grov. (2018) The Impact of Age-Related Macular Degeneration on Quality of Life and Its Association With Demographic Data: Results From the NEI VFQ-25 Questionnaire in a Norwegian Population. Gerontology and Geriatric Medicine 4, pages 233372141880160.
Crossref
Crossref
Maher Saleh, Anne-Sophie Gauthier, Bernard Delbosc & Marie Castelbou. (2018) Impact of Metamorphopsia on Quality of Life after Successful Retinal Detachment Surgery. Ophthalmologica 240:3, pages 121-128.
Crossref
Crossref
Melissa K. Jones, Bin Lu, Sergey Girman & Shaomei Wang. (2017) Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases. Progress in Retinal and Eye Research 58, pages 1-27.
Crossref
Crossref
Gerardo Andrés Dussán Torres. (2017) La calidad de vida relacionada con la salud en pacientes con degeneración macular asociada con la edad. Ciencia & Tecnología para la Salud Visual y Ocular 15:1, pages 27.
Crossref
Crossref
S Karadeniz Ugurlu, A E Kocakaya Altundal & M Altin Ekin. (2016) Comparison of vision-related quality of life in primary open-angle glaucoma and dry-type age-related macular degeneration. Eye 31:3, pages 395-405.
Crossref
Crossref
Meidong Zhu, Wijeyanthy Wijeyakumar, Adil R. Syed, Nichole Joachim, Thomas Hong, Geoffrey K. Broadhead, Haitao Li, Kehui Luo & Andrew Chang. (2016) Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 255:3, pages 475-484.
Crossref
Crossref
Colin S. Tan & SriniVas R. Sadda. 2017. Choroidal Disorders. Choroidal Disorders
89
116
.
Lijuan Zhang, Jianhai Du, Sally Justus, Chun-Wei Hsu, Luis Bonet-Ponce, Wen-Hsuan Wu, Yi-Ting Tsai, Wei-Pu Wu, Yading Jia, Jimmy K. Duong, Vinit B. Mahajan, Chyuan-Sheng Lin, Shuang Wang, James B. Hurley & Stephen H. Tsang. (2016) Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration. Journal of Clinical Investigation 126:12, pages 4659-4673.
Crossref
Crossref
Aniela K Krezel, Ruth E Hogg & Augusto Azuara-Blanco. (2015) Patient-reported outcomes in randomised controlled trials on age-related macular degeneration. British Journal of Ophthalmology 99:11, pages 1560-1564.
Crossref
Crossref
Lisa Ord, JoAnne Wright, Margaret DeAngelis & Michael Feehan. (2015) Quality of Life with Macular Degeneration Is Not as Dark as It May Seem: Patients’ Perceptions of the MacDQoL Questionnaire. Journal of Clinical Medicine 4:9, pages 1841-1852.
Crossref
Crossref
Li-Li Wang, Wen-Jia Liu, Hai-Yun Liu & Xun Xu. (2015) Single-site Baseline and Short-term Outcomes of Clinical Characteristics and Life Quality Evaluation of Chinese Wet Age-related Macular Degeneration Patients in Routine Clinical Practice. Chinese Medical Journal 128:9, pages 1154-1159.
Crossref
Crossref
Mitsuko Yuzawa, Kyoko Fujita, Kim U. Wittrup-Jensen, Christiane Norenberg, Oliver Zeitz, Kenji Adachi, Edward C.Y. Wang, Jeffrey Heier, Peter Kaiser, Victor Chong & Jean-Francois Korobelnik. (2015) Improvement in Vision-Related Function with Intravitreal Aflibercept. Ophthalmology 122:3, pages 571-578.
Crossref
Crossref
K. Michalska-Małecka, A. Kabiesz, M. Nowak & D. Śpiewak. (2015) Age related macular degeneration – challenge for future: Pathogenesis and new perspectives for the treatment. European Geriatric Medicine 6:1, pages 69-75.
Crossref
Crossref
Brooke LW Nesmith, Mark Ihnen & Shlomit Schaal. (2014) POOR RESPONDERS TO BEVACIZUMAB PHARMACOTHERAPY IN AGE-RELATED MACULAR DEGENERATION AND IN DIABETIC MACULAR EDEMA DEMONSTRATE INCREASED RISK FOR OBSTRUCTIVE SLEEP APNEA. Retina 34:12, pages 2423-2430.
Crossref
Crossref
Anika K. Tandon, Federico G. Velez, Sherwin J. Isenberg, Joseph L. Demer & Stacy L. Pineles. (2014) Binocular inhibition in strabismic patients is associated with diminished quality of life. Journal of American Association for Pediatric Ophthalmology and Strabismus 18:5, pages 423-426.
Crossref
Crossref
Tomohiro Iida, Aya Narimatsu, Kenji Adachi & Edward CY Wang. (2014) Anti-vascular Endothelial Growth Factor Outpatient Treatment Patterns in Patients with Exudative Age-related Macular Degeneration from a Japanese Hospital Claims Database. Journal of Health Economics and Outcomes Research 2:1, pages 41-52.
Crossref
Crossref